2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Follow Up on Advanced Melanoma: Should We Consider TIL as 2L / 3L Treatment Options?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Marlana Orloff
By 2020 ASCO Virtual Direct™ Highlights FEATURING Marlana Orloff
32 views
August 13, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

21:09
Exelixis

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Featured Video

23:14
AstraZeneca Oncology

Management Strategies for Nausea and Vomiting in First-line Maintena…

Feat. D. Czel, C. Arn
Skin
12:19
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Highlights on Melanoma: How Effective Is the Combination o…

Feat. M. Orloff
08:06
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Resectable Stage III Melanoma: Can We Avoid TLND…

Feat. M. Orloff
04:41
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Follow Up on Advanced Melanoma: Should We Consider TIL as …

Feat. M. Orloff
13:04
2020 ASCO Virtual Direct™ Highlights

2020 ASCO Update on Metastatic Melanoma: Is Toripalimab + Axitinib a…

Feat. M. Orloff